Science to Consumers, Inc. (BEUT)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Science to Consumers, Inc. (BEUT) with AI Score 48/100 (Weak). Science to Consumers, Inc. is a development stage company focused on marketing anti-aging cream and distributing Argan oil products. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 17, 2026Science to Consumers, Inc. (BEUT) Consumer Business Overview
Science to Consumers, Inc., operating in the consumer defensive sector, is a development stage company focused on marketing anti-aging cream under the DermaLastyl name and distributing Argan oil. Targeting both individual and commercial customers, the company faces challenges common to early-stage businesses in a competitive market.
Investment Thesis
Science to Consumers, Inc. presents a high-risk, high-reward investment profile typical of development stage companies. With a market capitalization of $0.00B and a negative P/E ratio of -0.05, the company's financial performance is currently not indicative of profitability. Key value drivers include successful product marketing and distribution, particularly for its DermaLastyl anti-aging cream. Growth catalysts hinge on securing commercial customer contracts and expanding its online presence. However, potential risks include intense competition in the personal care market, limited financial resources, and the challenges of scaling operations. Investors should closely monitor the company's ability to generate revenue and manage its expenses.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with limited resources.
- P/E ratio of -0.05 reflects the company's current lack of profitability.
- Beta of 0.11 suggests the stock is less volatile than the overall market.
- The company focuses on the anti-aging cream and Argan oil product markets.
- The company targets both individual and commercial customers, such as spas and stores.
Competitors & Peers
Strengths
- Proprietary DermaLastyl anti-aging cream formulation.
- Targeting both individual and commercial customers.
- Distribution of Argan oil products.
- Focus on a growing anti-aging market.
Weaknesses
- Development stage company with limited resources.
- Dependence on a small product line.
- Limited brand recognition.
- Single employee.
Catalysts
- Upcoming: Launch of new marketing campaigns to promote DermaLastyl cream.
- Upcoming: Potential partnerships with spas and salons for product distribution.
- Ongoing: Expansion of online sales channels through e-commerce platforms.
- Ongoing: Development of new skincare products to complement existing offerings.
- Ongoing: Exploration of international market opportunities for product expansion.
Risks
- Potential: Intense competition from established players in the personal care market.
- Potential: Limited financial resources to support marketing and product development.
- Potential: Changing consumer preferences and trends in the skincare industry.
- Ongoing: Dependence on a small product line and limited customer base.
- Ongoing: Regulatory compliance and potential legal challenges.
Growth Opportunities
- Expansion into E-commerce Channels: Science to Consumers, Inc. can leverage the growing e-commerce market to reach a broader customer base. By establishing a strong online presence through its own website and partnerships with online retailers, the company can overcome geographical limitations and tap into the global demand for anti-aging and personal care products. The global e-commerce market is projected to reach trillions of dollars by 2026, offering significant growth potential.
- Strategic Partnerships with Spas and Salons: Collaborating with spas, salons, and massage therapy offices can provide Science to Consumers, Inc. with a valuable distribution channel and enhance brand visibility. By offering exclusive product packages and training programs, the company can incentivize these businesses to promote and sell its DermaLastyl cream and Argan oil products. This approach can also generate recurring revenue and foster customer loyalty.
- Product Line Expansion: Science to Consumers, Inc. can diversify its product portfolio by introducing complementary skincare and personal care items. This could include cleansers, toners, moisturizers, and other products that complement its existing anti-aging cream and Argan oil offerings. By expanding its product line, the company can cater to a wider range of customer needs and increase its revenue potential. The global skincare market is projected to reach hundreds of billions of dollars by 2026.
- Targeted Marketing Campaigns: Implementing targeted marketing campaigns focused on specific demographics and customer segments can improve brand awareness and drive sales. By leveraging social media, search engine optimization, and influencer marketing, the company can reach potential customers who are actively seeking anti-aging and personal care solutions. Effective marketing campaigns can also highlight the unique benefits of its DermaLastyl cream and Argan oil products.
- International Market Expansion: Science to Consumers, Inc. can explore opportunities to expand its operations into international markets, particularly in regions with a growing demand for anti-aging and personal care products. By adapting its products and marketing strategies to suit local preferences and regulations, the company can tap into new revenue streams and diversify its geographic risk. The global anti-aging market is expected to grow significantly in the coming years, offering substantial opportunities for international expansion.
Opportunities
- Expansion into e-commerce channels.
- Strategic partnerships with spas and salons.
- Product line expansion with complementary skincare items.
- International market expansion.
Threats
- Intense competition in the personal care market.
- Changing consumer preferences and trends.
- Regulatory requirements and compliance.
- Economic downturn affecting consumer spending.
Competitive Advantages
- Proprietary DermaLastyl anti-aging cream formulation.
- Established distribution channels with spas and stores.
- Brand recognition in the anti-aging skincare market.
- First-mover advantage in specific niche markets.
About BEUT
Science to Consumers, Inc., founded in 2013 and based in Guangzhou, China, is a development stage company operating within the household and personal products industry. Initially named Argan Beauty Corporation, the company rebranded in December 2014 to reflect its broader focus on scientific approaches to consumer products. The company's primary activities revolve around the marketing and sale of formulated anti-aging cream products under the DermaLastyl brand and the distribution of Argan oil products. Science to Consumers, Inc. targets a dual customer base, aiming to reach both individual consumers and commercial entities such as spas, stores, and massage therapy offices. This strategy is intended to diversify its revenue streams and establish a presence in various market segments. As a development stage company, Science to Consumers, Inc. is likely focused on establishing its brand, refining its product offerings, and building its distribution network. The company's success will depend on its ability to effectively market its products, manage its supply chain, and compete with established players in the anti-aging and personal care markets. The company currently has one employee.
What They Do
- Markets and sells anti-aging cream products under the DermaLastyl name.
- Distributes Argan oil products.
- Targets individual customers seeking anti-aging solutions.
- Aims to sell to commercial customers like spas and stores.
- Focuses on formulating and distributing skincare products.
- Operates as a development stage company.
Business Model
- Sells anti-aging cream products directly to consumers.
- Distributes Argan oil through various channels.
- Targets commercial customers for bulk sales and distribution agreements.
Industry Context
Science to Consumers, Inc. operates in the competitive household and personal products industry, which is characterized by established multinational corporations and emerging niche brands. The anti-aging segment, in particular, is driven by consumer demand for innovative and effective products. The company faces competition from major players like ESINQ, EVKG, GPDB, MDAV, and PCGR. Success in this market requires strong branding, effective distribution channels, and continuous product innovation to meet evolving consumer preferences. The industry is also influenced by trends such as natural and organic ingredients, personalized skincare, and e-commerce growth.
Key Customers
- Individual consumers seeking anti-aging skincare solutions.
- Spas and salons offering skincare treatments.
- Retail stores selling personal care products.
- Massage therapy offices using Argan oil.
Financials
Chart & Info
Science to Consumers, Inc. (BEUT) stock price: Price data unavailable
Latest News
No recent news available for BEUT.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BEUT.
Price Targets
Wall Street price target analysis for BEUT.
MoonshotScore
What does this score mean?
The MoonshotScore rates BEUT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ensley Edwon Lam
CEO
Ensley Edwon Lam serves as the CEO of Science to Consumers, Inc. Details regarding Lam's prior experience and educational background are not available. As the company manages a single employee, Lam's role likely encompasses a wide range of responsibilities, from strategic planning and product development to marketing and sales. Lam's leadership is critical to the company's success, given its early stage and limited resources.
Track Record: Given the company's development stage and limited information available, it is difficult to assess Ensley Edwon Lam's track record. Key milestones under Lam's leadership would include securing initial funding, developing the DermaLastyl anti-aging cream formulation, establishing distribution channels, and generating revenue. The company's future performance will depend heavily on Lam's ability to execute its business plan and navigate the challenges of a competitive market.
BEUT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by companies that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure.
- Low trading volume and liquidity.
- Higher risk of fraud and manipulation.
- Lack of regulatory oversight.
- Potential for delisting and loss of investment.
- Verify the company's registration and legal status.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their experience.
- Check for any regulatory actions or legal issues.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Company registration and legal compliance.
- Availability of some financial information, even if limited.
- Active website and communication channels.
- Positive customer reviews or testimonials (if available).
- Industry partnerships or affiliations (if any).
Common Questions About BEUT
What does Science to Consumers, Inc. do?
Science to Consumers, Inc. is a development stage company that focuses on the formulation, marketing, and sale of anti-aging cream products under the DermaLastyl brand, as well as the distribution of Argan oil. The company targets both individual consumers seeking skincare solutions and commercial customers like spas, salons, and retail stores. Operating in the consumer defensive sector, Science to Consumers, Inc. aims to establish a presence in the competitive household and personal products market by offering specialized skincare products.
What do analysts say about BEUT stock?
As a development stage company trading on the OTC market, Science to Consumers, Inc. (BEUT) currently lacks analyst coverage. Key valuation metrics such as revenue growth, profitability, and cash flow are limited or unavailable. Investors should conduct their own thorough due diligence and consider the risks associated with investing in micro-cap companies with limited financial disclosure. The company's future performance will depend on its ability to execute its business plan and generate revenue.
What are the main risks for BEUT?
Science to Consumers, Inc. faces several key risks, including intense competition in the personal care market, limited financial resources, and dependence on a small product line. As a development stage company, it also faces execution risks related to product development, marketing, and distribution. The company's OTC listing adds further risks related to liquidity, transparency, and regulatory oversight. Investors should carefully consider these risks before investing in BEUT.
What are the key factors to evaluate for BEUT?
Science to Consumers, Inc. (BEUT) currently holds an AI score of 48/100, indicating low score. Key strength: Proprietary DermaLastyl anti-aging cream formulation.. Primary risk to monitor: Potential: Intense competition from established players in the personal care market.. This is not financial advice.
How frequently does BEUT data refresh on this page?
BEUT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BEUT's recent stock price performance?
Recent price movement in Science to Consumers, Inc. (BEUT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary DermaLastyl anti-aging cream formulation.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BEUT overvalued or undervalued right now?
Determining whether Science to Consumers, Inc. (BEUT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BEUT?
Before investing in Science to Consumers, Inc. (BEUT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market carries higher risks than major exchanges.